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EVALUATION OF ROLE OF XPERT MTB/RIF IN DIAGNOSIS OF EXTRA 
PULMONARY TUBERCULOSIS IN PATIENTS ATTENDING TERTIARY 
CARE HOSPITAL 
ABSTRACT: 
BACKGROUND: Globally extra pulmonary tuberculosis (EPTB) accounts for 25% 
of all tuberculosis cases. The Gene Xpert MTB/RIF assay is a newly developed, 
automated diagnostic molecular test recommended by WHO for diagnosing EPTB. In 
the current situation determination of MDR status is also important. Thus Xpert 
MTB/RIF assay plays a major role in diagnosing extrapulmonary tuberculosis and 
MDR status. 
 
AIM: To evaluate Xpert MTB/RIF assay in diagnosing Mycobacterium tuberculosis 
in extra pulmonary samples. 
 
MATERIALS AND METHODS: Around 500 extra pulmonary samples from 
patients suspected of extrapulmonary tuberculosis were tested. We evaluated the 
sensitivity and specificity of Xpert MTB/RIF with gold standard liquid culture and 
composite gold standard. Individually each sample type were analysed against liquid 
culture.  
RESULTS: In total 500 extrapulmonary samples were analysed against culture and 
composite gold standard. Compared to gold standard liquid culture, the sensitivity and 
specificity of Gene Xpert MTB/RIF assay was 94.7% and 99.5% respectively. While 
using Composite Gold Standard, Xpert MTB/RIF assay showed a pooled sensitivity of 
63.5% and specificity of 99.5%.  Multidrug resistance tuberculosis was reported in 
5.35% of extrapulmonary samples. 
CONCLUSION: We conclude that Xpert MTB/RIF assay can be used for diagnosing 
extra pulmonary tuberculosis with a good sensitivity and specificity. It also allows 
rapid identification of MDR TB. 
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